XK and viral infectious disease: In this context, Neuraminidase (NA), the second most abundant surface glycoprotein of IAV, has gained prominence2, as low-molecular-weight NA-inhibiting (NI) drugs (such as peramivir, zanamivir, oseltamivir, etc.)have demonstrated high efficacy in controlling active viral infections and alleviating symptoms3,4.